European Medicines Agency recommends restricting use of Pandemrix
The European Medicines Agency has recommended restricting use of Pandemrix, the vaccine issued following the outbreak of pandemic flu H1N1 in 2009.
Under the terms of the agreement, Affymetrix will pay approximately $73 million in cash to acquire Panomics.